National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Multiple Myeloma and Other Plasma Cell Neoplasms Treatment (PDQ®)     
Last Modified: 07/24/2008
Patient Version
Refractory Multiple Myeloma and Other Plasma Cell Neoplasms

Multiple myeloma and other plasma cell neoplasms are called refractory when the number of plasma cells continues to increase even though treatment is given.



Glossary Terms

multiple myeloma (MUL-tih-pul MY-eh-LOH-muh)
A type of cancer that begins in plasma cells (white blood cells that produce antibodies). Also called Kahler disease, myelomatosis, and plasma cell myeloma.
neoplasm (NEE-oh-PLA-zum)
An abnormal mass of tissue that results when cells divide more than they should or do not die when they should. Neoplasms may be benign (not cancer), or malignant (cancer). Also called tumor.
plasma cell (PLAZ-muh SEL)
A type of immune cell that makes large amounts of a specific antibody. Plasma cells develop from B cells that have been activated. A plasma cell is a type of white blood cell. Also called plasmacyte.
refractory
In medicine, describes a disease or condition that does not respond to treatment.